American Society of Hematology

Fig. 5.

Fig. 5. There was no difference in the DFS between the patients assigned to G-CSF (median, 2.3 years) and those assigned to placebo (median, 1.7 years) (P = .53).

There was no difference in the DFS between the patients assigned to G-CSF (median, 2.3 years) and those assigned to placebo (median, 1.7 years) (P = .53).

This Feature Is Available To Subscribers Only

Sign In or Create an Account